NCNA logo

NuCana (NCNA)

Profile

Full Name

NuCana plc

Ticker Symbol

NCNA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United Kingdom

IPO

September 28, 2017

Indexes

Not included

Website

http://www.nucana.com

Employees

20

Key Details

Price

$0.86(+4.16%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$8.31(+49.61% YoY)

PE ratio

-

Next earnings date

May 16, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.86
NCNA price is $0.86

30-Day Relative Volume

0.73
NCNA 30-day relative volume is 0.73

Price Performance

Price Today change

+4.16%
NCNA price is up +4.16% today

Price YTD change

-27.35%
NCNA price is down -27.35% since January 1st

Price 1-year change

-80.57%
NCNA price is down -80.57% year-on-year

Price 3-year change

-96.47%
NCNA price is down -96.47% over the past 3 years

Price Range

Price All-time high

$800.00
NCNA price is currently -99.89% below its historical high of $800.00

Price 3-year low

$0.69
NCNA price is currently +25.11% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$5.24M
NCNA market capitalization is $5.24 million

Market cap 3-year change

-89.76%
NCNA market capitalization is down -89.76% over the past 3 years

Market cap All-time high

$949.21M
NCNA market capitalization is currently -99.45% below its historical high of $949.21 million

Market cap sector rank

13.9%
NCNA market capitalization is higher than 13.9% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+169.63%
NCNA shares outstanding is up +169.63% year-on-year

Shares Outstanding 3-Year Change

+190.11%
NCNA shares outstanding is up +190.11% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.97
NCNA beta is 0.97

200-day SMA

$2.10
NCNA price is currently -58.93% below its 200-day simple moving average

50-day SMA

$0.89
NCNA price is currently -3.35% below its 50-day simple moving average

RSI

48.71
NCNA 14-day relative strength index is 48.71

Volume

0.73
NCNA 30-day relative volume is 0.73

ATR

$0.10
NCNA average true range is $0.10

10-day Historical Volatility

85.74%
NCNA 10-day historical volatility is 85.74%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
NCNA annual revenue value is unknown

Revenue Analysts estimate

-
NCNA annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
NCNA annual revenue 1-year change is unknown

Revenue Sector rank

-
NCNA annual revenue is unknown

EPS

EPS

-$8.31
NCNA annual earnings per share is -$8.31

EPS Analysts estimate

-$0.05
NCNA annual earnings per share is currently >+9900.00% higher than the consensus analysts' forecast

EPS 1-year change

+49.61%
NCNA annual earnings per share is up +49.61% year-on-year

EPS Sector rank

13.65%
NCNA annual earnings per share is higher than 13.65% of companies in Healthcare sector

Profit

Gross profit

-
NCNA annual gross profit value is unknown

Gross margin

-
NCNA annual gross profit margin value is unknown

Operating profit

-$29.40M
NCNA annual operating income is -$29.40 million

Operating margin

-
NCNA annual operating profit margin value is unknown

Net income

-$24.28M
NCNA annual net profit is -$24.28 million

Net margin

-
NCNA annual net profit margin value is unknown

Expenses

Total expenses

$29.40M
NCNA annual total expenses is $29.40 million

Operating expenses

$29.40M
NCNA annual total operating expenses is $29.40 million

Cost of goods sold

-
NCNA annual cost of goods sold value is unknown

Selling, general & administrative expenses

$6.37M
NCNA annual SGA is $6.37 million

Depreciation and amortization

$667.10K
NCNA annual depreciation & amortization is $667.10 thousand

Interest expense

-
NCNA annual interest expense value is unknown

Income tax

-$4.41M
NCNA annual income tax is -$4.41 million

EBIT & EBITDA

EBIT

-$29.40M
NCNA annual earnings before interest & taxes is -$29.40 million

EBITDA

-$28.73M
NCNA annual EBITDA is -$28.73 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$18.54M
NCNA annual total assets is $18.54 million

Non current assets

$3.15M
NCNA annual long term assets is $3.15 million

Current assets

$15.39M
NCNA annual total current assets is $15.39 million

Cash and cash equivalents

$8.47M
NCNA annual cash & cash equivalents is $8.47 million

Accounts receivable

-
NCNA annual accounts receivable value is unknown

Inventory

-
NCNA annual inventory value is unknown

Liabilities

Total liabilities

$11.07M
NCNA annual total liabilities is $11.07 million

Long term liabilities

$193.20K
NCNA annual total long term liabilities is $193.20 thousand

Current liabilities

$10.87M
NCNA annual total current liabilities is $10.87 million

Accounts payable

$3.39M
NCNA annual accounts payable is $3.39 million

Debt

Total debt

$238.40K
NCNA annual total debt is $238.40 thousand

Total debt 1-year change

-52.74%
NCNA annual total debt is down -52.74% year-on-year

Long term debt

$146.80K
NCNA annual long term debt is $146.80 thousand

Short term debt

$91.60K
NCNA annual short term debt is $91.60 thousand

Equity & Capital

Shareholders equity

$7.47M
NCNA annual stockholders equity is $7.47 million

Book value

$7.47M
NCNA annual book value is $7.47 million

Retained earnings

-$281.44M
NCNA annual retained earnings is -$281.44 million

Working capital

$4.52M
NCNA annual working capital is $4.52 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$24.43M
NCNA annual cash flow from operations is -$24.43 million

Cash from operations 1-year change

+25.73%
NCNA annual cash flow from operations is up +25.73% year-on-year

Cash from investing

$101.00K
NCNA annual cash flow from investing activities is $101.00 thousand

Cash from investing 1-year change

-97.19%
NCNA annual cash flow from investing activities is down -97.19% year-on-year

Cash from financing

$10.46M
NCNA annual cash flow from financing activities is $10.46 million

Cash from financing 1-year change

+15971.78%
NCNA annual cash flow from financing activities is up +15971.78% year-on-year

CAPEX

CAPEX

-
NCNA annual capital expenditures value is unknown

CAPEX 1-year change

-
NCNA annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$24.81M
NCNA annual free cash flow is -$24.81 million

Free cash flow 1-year change

+25.93%
NCNA annual free cash flow is up +25.93% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
NCNA annual gross profit margin value is unknown

Operating margin

-
NCNA annual operating profit margin value is unknown

Net margin

-
NCNA annual net profit margin value is unknown

ROA & ROE

ROA

-130.97%
NCNA annual return on assets is -130.97%

ROE

-324.98%
NCNA annual return on equity is -324.98%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
NCNA price to earnings ratio value is unknown

PE ratio Sector rank

-
NCNA price to earnings ratio is unknown

PB Ratio

PB ratio

0.70
NCNA price to book ratio is 0.70

PB ratio Sector rank

36.71%
NCNA price to book ratio is higher than 36.71% of companies in Healthcare sector

PS Ratio

PS ratio

-
NCNA price to sales ratio value is unknown

PS ratio Sector rank

-
NCNA price to sales ratio is unknown

Enterprise value

Enterprise value

-$2.99M
NCNA enterprise value is -$2.99 million

Enterprise value Sector rank

8.18%
NCNA enterprise value is higher than 8.18% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.10
NCNA EV/EBITDA is 0.10

EV/EBITDA Sector rank

67.04%
NCNA EV/EBITDA is higher than 67.04% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.42
NCNA annual current ratio is 1.42

Quick ratio

-
NCNA annual quick ratio value is unknown

Leverage

Debt to equity

0.03
NCNA annual debt to equity ratio is 0.03

Interest coverage ratio

-
NCNA annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
NCNA piotroski f-score value is unknown

Altman Z-Score

-
NCNA altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Aug 19, 24 Oppenheimer
Outperform
Jul 23, 24 Oppenheimer
Outperform
Jul 22, 24 Oppenheimer
Outperform
Apr 1, 24 Oppenheimer
Outperform
Nov 21, 23 Oppenheimer
Outperform
Sep 6, 23 Truist Securities
Buy
Aug 18, 23 Oppenheimer
Outperform
May 22, 23 Oppenheimer
Outperform
Sep 22, 22 Jefferies
Buy
Mar 3, 22 Cowen & Co.
Market Perform

Institutional Ownership

Similar stocks

GMDA logo
Gamida Cell (GMDA)
NSTG logo
NanoString Technologies (NSTG)
Klotho Neurosciences (KLTO)
LMDX logo
LumiraDx Limited (LMDX)
GTBP logo
GT Biopharma (GTBP)
PTN logo
Palatin Technologies (PTN)
LUCY logo
Innovative Eyewear (LUCY)
AEMD logo
Aethlon Medical (AEMD)
ALZN logo
Alzamend Neuro (ALZN)
  • What is the ticker symbol for NuCana?
  • Does NuCana pay dividends?
  • What sector is NuCana in?
  • What industry is NuCana in?
  • What country is NuCana based in?
  • When did NuCana go public?
  • Is NuCana in the S&P 500?
  • Is NuCana in the NASDAQ 100?
  • Is NuCana in the Dow Jones?
  • When was NuCana's last earnings report?
  • When does NuCana report earnings?

What is the ticker symbol for NuCana?

The ticker symbol for NuCana is NASDAQ:NCNA

Does NuCana pay dividends?

No, NuCana does not pay dividends

What sector is NuCana in?

NuCana is in the Healthcare sector

What industry is NuCana in?

NuCana is in the Biotechnology industry

What country is NuCana based in?

NuCana is headquartered in United Kingdom

When did NuCana go public?

NuCana's initial public offering (IPO) was on September 28, 2017

Is NuCana in the S&P 500?

No, NuCana is not included in the S&P 500 index

Is NuCana in the NASDAQ 100?

No, NuCana is not included in the NASDAQ 100 index

Is NuCana in the Dow Jones?

No, NuCana is not included in the Dow Jones index

When was NuCana's last earnings report?

NuCana's most recent earnings report was on Mar 20, 2025

When does NuCana report earnings?

The next expected earnings date for NuCana is May 16, 2025
On this page